News Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-05-15 pm EDT			5-day change	1st Jan Change
3.580 ^USD	-1.10%		-16.55%	-41.79%

May. 05	Myriad Genetics, Inc., Q1 2026 Earnings Call, May 05, 2026
May. 05	Myriad Genetics, Inc. Reiterates Earnings Guidance for the Full Year 2026	CI

All News

Mentions Relevance

May. 15	Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life	GL
May. 07	Myriad Genetics : to Participate in Upcoming Investor Healthcare Conferences	PU
May. 07	Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences	GL
May. 05	Myriad Genetics, Inc., Q1 2026 Earnings Call, May 05, 2026
May. 05	Myriad: Q1 Earnings Snapshot	AQ
May. 05	Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business	GL
May. 05	Myriad Genetics, Inc. Reiterates Earnings Guidance for the Full Year 2026	CI
May. 05	Myriad Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
May. 01	Myriad Genetics National Survey, 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan	AQ
Apr. 30	Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan	GL
Apr. 28	Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026	GL
Apr. 16	Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026	GL
Apr. 16	Myriad Genetics Announces Six Abstracts and Podium Presentations at AACR Annual Meeting	CI
Apr. 14	Myriad Genetics Secures Japanese Regulatory Approval For Prostate Cancer Diagnostic Test	MT
Apr. 14	Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan	GL
Apr. 14	Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan	AQ
Apr. 14	Myriad Genetics Inc Expands Access For Mychoice Test To Prostate Cancer Patients In Japan	CI
Apr. 09	Myriad Genetics Announces New Data Presentations At Society of Gynecologic Oncology Annual Meeting	CI
Apr. 09	Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting	GL
Mar. 22	Myriad Genetics, Inc.(NasdaqGS:MYGN) dropped from S&P 600	CI
Mar. 22	Myriad Genetics, Inc.(NasdaqGS:MYGN) dropped from S&P Composite 1500	CI
Mar. 22	Myriad Genetics, Inc.(NasdaqGS:MYGN) dropped from S&P 600 Health Care	CI
Mar. 22	Myriad Genetics, Inc.(NasdaqGS:MYGN) dropped from S&P 1000	CI
Mar. 17	Myriad Genetics Gets US FDA Approval of MyChoice as Companion Diagnostic for Ovarian Cancer Drug	MT
Mar. 17	Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer	GL